All Outputs (6)

Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria (2024)
Journal Article
Surendran, A., Turnbull, A., Flockhart, A., Findlay-Greene, F., Nowosielska, M., Morrison, D., Mincher, D. J., & Donnellan, S. (online). Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria. All Life, https://doi.org/10.1080/26895293.2024.2379309

We hypothesise that antimicrobial resistance (AMR) cannot be overcome by simply ‘drugging’ single biological targets, therefore, our focus is developing broad-spectrum therapeutics. Herein we present the synthesis of two novel spacer-linked, anthraqu... Read More about Design of a new class of broad-spectrum therapeutics targeted to drug-resistant bacteria.

Phenotypic Variation as an Important Aspect of Staphylococcal Pathogenesis (2024)
Journal Article
Morrison, D. (in press). Phenotypic Variation as an Important Aspect of Staphylococcal Pathogenesis. Frontiers in Cellular and Infection Microbiology,

An editorial which frames the Research Topic's aims and objectives placing its findings in a broader context. Staphylococcus aureus and coagulase-negative staphylococci are medically important pathogens known for a pronounced phenotypic variabili... Read More about Phenotypic Variation as an Important Aspect of Staphylococcal Pathogenesis.

Safety Assessment RP709 protease (subtilisin) produced by Bacillus licheniformis DSM 33099 (ProAct 360) (2024)
Report
Morrison, D. (2024). Safety Assessment RP709 protease (subtilisin) produced by Bacillus licheniformis DSM 33099 (ProAct 360). Food Standards Agency

An application was submitted to the Food Standards Agency in March 2021 from DSM Nutritional Products LTD (“the applicant”) for the new authorisation of an additive (ProAct 360) containing protease (subtilisin), under the category of “zootechnical ad... Read More about Safety Assessment RP709 protease (subtilisin) produced by Bacillus licheniformis DSM 33099 (ProAct 360).

Safety Assessment RP1047 Quillaja saponaria and Yucca schidigera (Magni-Phi®) (2024)
Report
Morrison, D. (2024). Safety Assessment RP1047 Quillaja saponaria and Yucca schidigera (Magni-Phi®). Food Standards Agency

An application was submitted to the Food Standards Agency in April 2021 from Phibro Animal Health Corporation (“the applicant”) for the new authorisation of an additive (Magni-Phi®), a natural preparation of powdered dry Quillaja saponaria and dry Yu... Read More about Safety Assessment RP1047 Quillaja saponaria and Yucca schidigera (Magni-Phi®).

Assessment of the safety and efficacy of Guanidinoacetic acid (Creamino®) as a feed additive for all animal species (2024)
Report
Morrison, D. (2024). Assessment of the safety and efficacy of Guanidinoacetic acid (Creamino®) as a feed additive for all animal species. Food Standards Agency

An application was submitted to the Food Standards Agency in May 2021 from AlzChem Trostberg GmbH (“the applicant”) for the new use authorisation of an additive guanidinoacetic acid (Creamino®), under the category of ‘nutritional additives” and funct... Read More about Assessment of the safety and efficacy of Guanidinoacetic acid (Creamino®) as a feed additive for all animal species.

Literature Review on Antimicrobial Resistance In Relation To The Environment In Scotland (2024)
Report
Wojcik, G., Anderson, L., Johnston, L., Moffat, S., & Morrison, D. (2024). Literature Review on Antimicrobial Resistance In Relation To The Environment In Scotland. Environmental Standards Scotland

Commissioned literature review on the key causes, impacts and controls for anti-microbial resistance (AMR) in the environment that are relevant to Scotland. The review summarises what is currently known about the impact of AMR on the environment and... Read More about Literature Review on Antimicrobial Resistance In Relation To The Environment In Scotland.